Search
for

    Sort by

    Research 30 of 262

    1. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome Urology · 2018 · 35 citations
    2. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    3. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation Expert Opinion on Drug Safety · 2012 · 71 citations
    4. Post-Finasteride Syndrome: An Underestimated Phenomenon Urology and andrology · 2017
    5. (379) The Effect of 5-α Reductase Inhibitor on Male Reproductive Function The Journal of Sexual Medicine · 2024
    6. Risks and side effects in the medical management of benign prostatic hyperplasia Prostate International · 2023 · 26 citations
    7. Male Sex Hormones in Andrology Today Springer eBooks · 2022 · 1 citations
    8. Associations between semen quality and lower urinary tract symptoms in ageing male Journal of Men's Health · 2010
    9. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. PubMed · 2012 · 13 citations
    10. Abstracts from the current global literature: Finasteride and sexual dysfunction Indian journal of sexually transmitted diseases and AIDS · 2017
    11. Post‐finasteride syndrome: real or myth? Trends in Urology & Men s Health · 2024
    12. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction Fertility and Sterility · 2021 · 8 citations
    13. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    14. Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial The Journal of Urology · 2017
    15. The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being Current Sexual Health Reports · 2015 · 1 citations
    16. The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression Korean Journal of Urology · 2014 · 75 citations
    17. The Men’s Training Cup Keep Training: a masturbation aid improves intravaginal ejaculatory latency time and Erection Hardness Score in patients who are unable to delay ejaculation Sexual Medicine · 2023 · 2 citations
    18. Clinical review of ejaculatory dysfunction Reproductive Medicine and Biology · 2019 · 24 citations
    19. Finasteride and sexual side effects Indian Dermatology Online Journal · 2012 · 39 citations
    20. Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review Journal of Clinical Medicine · 2021 · 34 citations
    21. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    22. Male infertility and genitourinary birth defects: there is more than meets the eye Fertility and Sterility · 2020 · 26 citations
    23. Gynécomastie et finastéride (Propecia®) : 4 nouveaux cas Annales De Dermatologie Et De Venereologie · 2004 · 3 citations
    24. The pathophysiology of delayed ejaculation Translational Andrology and Urology · 2016 · 21 citations
    25. Introduction Fertility and Sterility · 2020
    26. Lasers, lights, and compounds for hair loss in aesthetics Clinics in Dermatology · 2021 · 3 citations
    27. Exploring rat corpus cavernosum alterations induced by finasteride treatment and withdrawal Andrology · 2023 · 1 citations
    28. Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects The Journal of Sexual Medicine · 2012 · 35 citations
    29. Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm The World Journal of Men's Health · 2020 · 17 citations
    30. Design and Evaluation of Hair Growth - Hair Fall Oil Formulation from Botanicals Bangladesh pharmaceutical journal · 2024